Cardlytics (CDLX) Reports Acquisition of Dosh for $275M in Cash and Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cardlytics (CDLX) Prices 3.85M Share Common Offering at $130/Sh
March 3, 2021 6:11 AM ESTCardlytics, Inc. (NASDAQ: CDLX) today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock, at a price to the public of $130.00 per share. The gross proceeds to Cardlytics from the offering, before deducting underwriting discounts and commissions and... More
Cardlytics (CDLX) Misses Q4 EPS by 2c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Above Consensus
March 1, 2021 6:43 AM ESTCardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $67.1 million versus the consensus estimate of $60.89 million.
Fourth Quarter 2020 Financial Results
Total revenue was $67.1 million, a decrease of (3.2)%, compared to $69.3 million in the fourth quarter of 2019.Net loss attributable to common stockholders was $(6.8) million, or $(0.24) per diluted share, based on 27.7 million weighted-average common shares outstanding, compared to a net income attributable to common stockholders of $3.4 million, or $0.12 per diluted... More